Stock Research: SI-BONE

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

SI-BONE

NMQ:SIBN US8257041090
83
  • Value
    59
  • Growth
    69
  • Safety
    Safety
    42
  • Combined
    60
  • Sentiment
    87
  • 360° View
    360° View
    83
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

SI-BONE, Inc. is a medical device company focused on solving musculoskeletal disorders of sacropelvic anatomy; it specializes in minimally invasive surgical implant systems for sacroiliac joint dysfunction, pelvic fixation, and pelvic fractures. Its main businesses include iFuse, iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite implant systems. The company operates within the United States. In the last fiscal year, the company had a market cap of $727 million, profits of $132 million, revenue of $167 million, and 349 employees.

more

ANALYSIS: With an Obermatt 360° View of 83 (better than 83% compared with alternatives) for 2026, overall professional sentiment and financial characteristics for the stock SI-BONE are very positive. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for SI-BONE. The consolidated Value Rank has an attractive rank of 59, which means that the share price of SI-BONE is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 59% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 69, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. In addition, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 87. But the company’s financing is risky with a Safety rank of 42. This means 58% of comparable companies have a safer financing structure than SI-BONE. ...read more

more
Index
NASDAQ
D.J. US Medical Equipment
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 9-Apr-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
59 33 25 15
Growth
69 67 100 9
Safety
Safety
42 50 39 67
Sentiment
87 47 73 30
360° View
360° View
83 44 80 8
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
53 81 84 71
Opinions Change
14 50 50 50
Pro Holdings
n/a 46 60 18
Market Pulse
100 25 48 47
Sentiment
87 47 73 30
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
59 33 25 15
Growth
69 67 100 9
Safety Safety
42 50 39 67
Combined
60 52 62 9
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
56 34 24 31
Price vs. Earnings (P/E)
90 30 30 20
Price vs. Book (P/B)
36 36 30 30
Dividend Yield
1 1 1 1
Value
59 33 25 15
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
69 66 65 63
Profit Growth
30 84 76 15
Capital Growth
76 18 89 13
Stock Returns
50 53 100 37
Growth
69 67 100 9
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
69 65 46 57
Refinancing
62 65 65 69
Liquidity
30 15 24 28
Safety Safety
42 50 39 67

Similar Stocks

Discover high‑ranked alternatives to SI-BONE and broaden your portfolio horizons.

Micron

NSQ:MU
Country: USA
Industry: Semiconductors
Size: XX-Large
Full Stock Analysis

Salesforce

NYQ:CRM
Country: USA
Industry: Application Software
Size: XX-Large
Full Stock Analysis

Microsoft

NSQ:MSFT
Country: USA
Industry: Systems Software
Size: XX-Large
Full Stock Analysis

ResMed

NYQ:RMD
Country: USA
Industry: Health Care Equipment
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

This is a high-quality, high-growth stock with positive sentiment. However, the financing is on the riskier side. It is best for a growth-focused investor willing to accept higher financial risk for potentially higher shareholder returns.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: